Pomerantz Appointed Lead Counsel in Deutsche Bank AG Securities Litigation

On December 28, 2020, U.S District Judge Kevin McNulty of the District of New Jersey appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Yun Wang in Karimi v. Deutsche Bank AG, 20-cv-8978 (D.N.J.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations regarding Deutsche Bank AG’s failure to adequately report deficiencies in its anti-money laundering controls.

Read More

Pomerantz Appointed Co-Lead Counsel in Blink Charging Securities Litigation

On December 21, 2020, U.S District Judge Edwin G. Torres of the Southern District of Florida appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Tianyou Wu, Alexander Yu and H. Marc Joseph in Bush v. Blink Charging Company, 20-cv-23527 (S.D. Fla.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Blink Charging Company had…

Read More

Pomerantz Appointed Lead Counsel in MEI Pharma Securities Litigation

On December 17, 2020, U.S District Judge William Q. Hayes of the Souther District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Ramesh Mahalingam in Bahat v. MEI Pharma, Inc., 20-cv-1543 (S.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that MEI Pharma, Inc. had overstated the efficacy of Pracinostat, one of its new drug candidates.

Read More

Pomerantz Appointed Lead Counsel in Colony Credit Real Estate Securities Litigation

On December 11, 2020, U.S District Judge Philip S. Guiierrez of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Philip Nuccetelli, Alan Cohen, and Roger P. Martyna (collectively, “Colony Credit Investor Group”), in Peters v. Colony Credit Real Estate, 20-cv-8305 (C.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that…

Read More

Pomerantz Appointed Co-Lead Counsel in Odonate Therapeutics Securities Litigation

On December 14, 2020, U.S District Judge Marilyn L. Huff of the Southern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Kevin Kendall in Kendall v. Odonate Therapeutics, Inc., 20-cv-1828 (S.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Odonate Therapeutics, Inc. had misrepresented the safety and commercial viability of one of its cancer treatments.

Read More

Pomerantz Wins European Pensions Thought Leadership Award

On December 10, 2020 Pomerantz was honored by European Pensions with its prestigious Thought Leadership Award – a recognition that the Firm “has demonstrated the possibility to make a real, material difference to the pension fund space.” In honoring Pomerantz’s thought leadership, European Pensions recognized the Firm’s long tradition of developing innovative ways to advance institutional investors’ interests. Beyond expanding European pension funds’ access…

Read More

Pomerantz Appointed Co-Lead Counsel in Alteryx Securities Litigation

On November 13, 2020, U.S District Judge David O. Carter of the Central District of California — Southern Division appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiffs Alejandro Handal, Steven Cardoza, and Homayon Farnoodymeher (collectively, the “Alteryx Investor Group”) in In re Alteryx, Inc. Securities Litigation, 20-cv-1540 (C.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Alteryx, Inc. failed to disclose…

Read More

Pomerantz Appointed Lead Counsel in HDFC Bank Securities Litigation

On December 9, 2020, U.S District Judge Eric Komitee of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Meitav Dash Provident Funds and Pension Ltd. in Arora v. HDFC Bank Limited, 20-cv-4140 (E.D.N.Y.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that HDFC Bank Limited failed to disclose that the Company had ineffective controls governing its financial reporting and lending practices in its vehicle-financing operations.

Read More

Pomerantz Appointed Co-Lead Counsel in Honeywell Securities Litigation

On December 3, 2020, U.S District Judge William J. Martini of the District of New Jersey appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Iron Workers Local 580 – Joint Funds in Kanefsky v. Honeywell International Inc., 18-cv-15536 (D.N.J.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Honeywell International Inc. issued repeated misstatements about its asbestos liabilities.

Read More

Pomerantz Appointed Lead Counsel in Paysign Securities Litigation

On December 2, 2020, U.S District Judge Gloria M. Navarro of the District of Nevada appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Johann Francisconi and Raheel Shahzad (collectively, the “Paysign Investor Group”) in In re Paysign, Inc. Securities Litigation, 20-cv-553 (D. Nev.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Paysign, Inc. failed to disclose that the Company had ineffective controls governing its financial reporting and information technology.

Read More

Pomerantz Appointed Lead Counsel in YayYo Securities Litigation

On December 1, 2020, U.S District Judge Stephen V. Wilson of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Bernard Bednarz in Jason Hamlin v. YayYo, Inc. et al, 2:20-cv-08235-SVW-AFM, a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that YayYo, Inc. issued a materially deficient Registration Statement for its initial public offering, violating their independent, affirmative duty to provide adequate disclosures about adverse conditions, risk, and uncertainties.

Read More

Pomerantz Defeats Zynerba Pharamaceuticals Motion to Dismiss

On November 25, 2020, Pomerantz scored a victory for injured Zynerba Pharmaceuticals, Inc. (“Zynerba”) shareholders when Judge Nitza I. Quiñones Alejandro of the United States District Court in the Eastern District of Pennsylvania, issued an order in Whiteley v. Zynerba Pharmaceuticals, Inc. et al (2:19-cv-04959-NIQA) denying in the defendants’ motion to dismiss the class action complaint. The complaint alleges that the defendants issued misleading statements touting Zygel and the BELIEVE I Trial, and representing Zygel as addressing safety issues with current treatment options…

Read More

Pomerantz Appointed Lead Counsel in LexinFintech Securities Litigation

On November 19, 2020, U.S District Judge Michael H. Simon of the District of Oregon appointed Pomerantz LLP as Lead Counsel in In re LexinFintech Holdings Ltd. Sec. Litig, 20-cv-1562 (D. Or.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that LexinFintech Holdings Ltd.’s failed to maintain consistent operational and compliance policies during the COVID-19 pandemic, rendering the offering documents for its initial public offering invalid.

Read More

Pomerantz Appointed Lead Counsel in Anaplan Securities Litigation

On November 12, 2020, U.S District Judge Richard Seeborg of the Northern District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Fadel Sakkal in Grobler v. Anaplan Inc. et al, 20-cv-05959-RS (N.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors regarding allegations that Anaplan, Inc. failed to disclose material adverse information about the performance of its sales organization.

Read More

Pomerantz Achieves Major Victory for BofI Investors

Pomerantz LLP won a major victory for investors when the Ninth Circuit Court of Appeals reversed, in part, the district court’s dismissal of a securities fraud class action against BofI Holding, Inc., now known as Axos Financial Inc., on loss causation grounds. BofI, short for Bank of Internet, operated as the holding company for BofI Federal Bank, now known as Axos Bank. Pomerantz is lead counsel in this litigation, in which it is alleged that BofI misled investors by misrepresenting and omitting material information in their public statements…

Read More

Pomerantz Appointed Lead Counsel in STAAR Surgical Securities Litigation

On October 29, 2020, U.S District Judge James V. Selna of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Daniel Mangas in Alwazzan v. STAAR Surgical Company, 20-cv-1533 (C.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors…

Read More

Pomerantz Appointed Lead Counsel in Conn's Securities Litigation

On October 27, 2020, U.S District Judge Lynn N. Hughes of the Southern District of Texas appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Ronny Alexander in Uddin v. Conn's Inc., 20-cv-1705 (S.D. Tex.), a securities litigation being pursued on behalf of a class of defrauded investors…

Read More

Pomerantz Achieves Victory on Behalf of Apple iPhone 4s Owners

Pomerantz LLP achieved a significant victory on behalf of consumers in a case brought by iPhone 4s owners who downloaded Apple’s iOS 9 operating system onto their devices. On October 7, 2020, Judge Sterling Johnson, Jr. of the United States District Court for the Eastern District of New York granted Plaintiffs’ motion for class certification in Lerman v. Apple Inc.

Read More